Skip to main content
Premium Trial:

Request an Annual Quote

Stepahne Altaba, Camille Chypre, and Anne Jacquet

Genomic Vision has expanded its senior management team by appointing Stephane Altaba as vice-president of corporate development, Camille Chypre as vice-president of research and development, and Anne Jacquet as medical director. Altaba previously served as vice-president of corporate business development at Nordic Pharma Group. Prior to that, he was director of corporate licenses at Sanofi. Chypre comes to Genomic Vision after serving as executive vice president at LXRepair. Jacquet has worked in preclinical and clinical research in the field of cardiovascular disease and oncology, prior to joining Genomic Vision. 

The Scan

Polygenic Risk Score to Predict Preeclampsia, Gestational Hypertension in Pregnant Women

Researchers in Nature Medicine provide new mechanistic insights into the development of hypertensive disorders of pregnancy, which may help develop therapeutics.

New Oral Nanomedicine Strategy Targets Gut-Brain Axis to Treat IBD

A new paper in Science Advances describes a platform to design polyphenol-armored oral medicines that are effective at treating inflammatory bowel disease.

Phylogenetic Data Enables New Floristic Map

Researchers in Nature Communications use angiosperm phylogenetic data to refine the floristic regions of the world.

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.